Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niclosamide in Familial Adenomatous Polyposis
NCT04296851Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Feb 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in familial adenomatous polyposis (FAP) comparing Niclosamide with Placebo (2 arms). Primary endpoint: Mean percentage change of the number and size of polyps in colon and/or duodenum at 6 months. Status: unknown.
02
Drugs
niclosamide
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT04296851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04296851.